Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review)
Therapeutic resistance is the main obstacle to long-term survival in lung cancer, with metabolic reprogramming identified as a key factor in this failure. Accumulating evidence suggests that metabolic reprogramming, particularly the aberrant metabolism of lactate, plays a crucial role in the progression of lung cancer...